DANAHER Inactive Instrument
DANAHER Stock Other OTC
Equities
US2358513008
Advanced Medical Equipment & Technology
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Hours!
Take advantage of the offer
* See conditions on site
| Sales 2024 * | 23.9B 32.53B | Sales 2025 * | 26B 35.4B | Capitalization | 196B 267B |
|---|---|---|---|---|---|
| Net income 2024 * | 4.44B 6.04B | Net income 2025 * | 5.35B 7.28B | EV / Sales 2024 * | 8.57 x |
| Net Debt 2024 * | 8.58B 11.69B | Net Debt 2025 * | 2.35B 3.2B | EV / Sales 2025 * | 7.63 x |
| P/E ratio 2024 * |
44.6
x | P/E ratio 2025 * |
36.6
x | Employees | - |
| Yield 2024 * |
0.41% | Yield 2025 * |
0.44% | Free-Float | 74.91% |
More Fundamentals
* Assessed data
More news
Latest transcript on DANAHER
More recommendations
More press releases
More news
| Managers | Title | Age | Since |
|---|---|---|---|
Rainer Blair
CEO | Chief Executive Officer | 60 | 09-12-31 |
Steven Rales
FOU | Founder | 72 | 82-12-31 |
Mitchell Rales
FOU | Founder | 67 | 82-12-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Mitchell Rales
FOU | Founder | 67 | 82-12-31 |
Alan Spoon
BRD | Director/Board Member | 72 | 99-06-30 |
Steven Rales
FOU | Founder | 72 | 82-12-31 |
Danaher Corporation is an industrial and technologic group organized around two families of products:
- medical equipment (70.1% of net sales): diagnostic equipment, digital imaging systems, optical instruments, microscopes, consumables, etc.;
- professional instruments of analysis (29.9%): systems of quality control of waters, disinfection, etc.
Net sales are distributed geographically as follows: the United States (40.1%), China (13.2%) and other (46.7%).
Calendar
2024-07-17
- Q2 2024 Earnings Release (Projected)
Related indices
| 1st Jan change | Capi. | |
|---|---|---|
| +11.76% | 228B | |
| +17.63% | 141B | |
| +28.27% | 110B | |
| +0.53% | 65.88B | |
| +16.38% | 54.3B | |
| +6.33% | 52.39B | |
| +11.18% | 45.22B | |
| +5.05% | 37.12B | |
| +26.80% | 32.32B |
